Journal of Autism and Developmental Disorders

, Volume 31, Issue 6, pp 529–535 | Cite as

Dysregulation of Reelin and Bcl-2 Proteins in Autistic Cerebellum

  • S. Hossein Fatemi
  • Joel M. Stary
  • Amy R. Halt
  • George R. Realmuto


Autism is a severe neurodevelopmental disorder with potential genetic and environmental causes. Cerebellar pathology including Purkinje cell atrophy has been demonstrated previously. We hypothesized that cell migration and apoptotic mechanisms may account for observed Purkinje cell abnormalities. Reelin is an important secretory glycoprotein responsible for normal layering of the brain. Bcl-2 is a regulatory protein responsible for control of programmed cell death in the brain. Autistic and normal control cerebellar corteces matched for age, sex, and post-mortem interval (PMI) were prepared for SDS-gel electrophoresis and Western blotting using specific anti-Reelin and anti-Bcl-2 antibodies. Quantification of Reelin bands showed 43%, 44%, and 44% reductions in autistic cerebellum (mean optical density ± SD per 30 μg protein 4.05 ± 4.0, 1.98 ± 2.0, 13.88 ± 11.9 for 410 kDa, 330 kDa, and 180 kDa bands, respectively; N = 5) compared with controls (mean optical density ± SD per 30 μg protein, 7.1 ± 1.6, 3.5 ± 1.0, 24.7 ± 5.0; N = 8, p < 0.0402 for 180 kDa band). Quantification of Bcl-2 levels showed a 34% to 51% reduction in autistic cerebellum (M ± SD per 75 μg protein 0.29 ± 0.08; N = 5) compared with controls (M ± SD per 75 μg protein 0.59 ± 0.31; N = 8, p < 0.0451). Measurement of β-actin (M ± SD for controls 7.3 ± 2.9; for autistics 6.77 ± 0.66) in the same homogenates did not differ significantly between groups. These results demonstrate for the first time that dysregulation of Reelin and Bcl-2 may be responsible for some of the brain structural and behavioral abnormalities observed in autism.

Cerebellum autism Reelin Bcl-2 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adams, J. M., & Cory, S. (1998). The Bcl-2 protein family: Arbiters of cell survival. Science, 281, 1322–1326.PubMedGoogle Scholar
  2. Bauman, M. L. (1996). Neuroanatomic observations of the brain in pervasive developmental disorders. Journal of Autism and Developmental Disorders, 26, 199–203.PubMedGoogle Scholar
  3. Bryson, S. E., & Smith, I. M. (1998). Epidemiology of autism: Prevalence, associated characteristics, and implications for research and service delivery. Mental Retardation and Developmental Disorders Research Review, 4, 9–103.Google Scholar
  4. Chan, W. Y., & Yew, I. Y. (1998). Apoptosis and Bcl-2 oncoprotein expression in the human fetal central nervous system. Anatomical Record, 252, 165–175.PubMedGoogle Scholar
  5. Chen, R. W., & Chuang, D. M. (1999). Long-term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression: A prominent role in neuroprotection against excitotoxicity. Journal of Biological Chemistry, 274, 6039–6042.PubMedGoogle Scholar
  6. DeBergeyck, V., Nakajima, K., Lambert de Roubroit, C., Naerhuyzen, B., Goffinet, A. M., & Miayata, T. et al. (1997). A truncated Reelin protein is produced but not secreted in the ‘Orleans’ reeler mutation (Rein[rl-Orl]). Molecular Brain Research, 50, 85–90.PubMedGoogle Scholar
  7. Falconer, D. S. (1951). Two new mutants, trembler and “Reeler”, with neurological actions in the house mouse. Journal of Genetics, 50, 182–201.Google Scholar
  8. Fatemi, S. H., Emamian, E. S., Kist, D., Sidwell, R. W., Nakajima, K., Akhter, P., et al. (1999). Defective corticogenesis and reduction in Reelin immunoreactivity in the cortex and hippocampus of prenatally infected neonatal mice. Molecular. Psychiatry, 4, 145–154.PubMedGoogle Scholar
  9. Fatemi, S. H., Earle, J., & McMenomy, T. (2000). Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Molecular Psychiatry, 5, 654–663.PubMedGoogle Scholar
  10. Fatemi, S. H. (2001). Reelin mutations in mouse and man: from reeler mouse to schizophrenia, mood disorders, autism and lissencephaly. Molecular Psychiatry, 6, 129–133.PubMedGoogle Scholar
  11. Fatemi, S. H., Halt, A. R., Stary, J. M., Realmuto, G. M., & Jalali-Mousavi, M. (2001). Reduction in anti-apoptotic protein Bcl2 in autistic cerebellum. NeuroReport, 12, 929–933.PubMedGoogle Scholar
  12. Fatemi, S. H., Halt, A. R., Earle, J., Kist, D. A., Realmuto, G., Thuras, P. D., & Merz, A. (2000). Reduced Purkinje cell size in autistic cerebellum. Biological Psychiatry, 47, 128S.Google Scholar
  13. Guidotti, A., Auta, J., Davis, J., Dwivedi, Y., Grayson, D., Impagnatiello, F., et al. (2000). Decrease in Reelin and glutamic acid decarboxylase 67 (GAD67) expression in schizophrenia and bipolar disorder: A post-mortem brain study. Archives in General Psychiatry, 57, 1061–1069Google Scholar
  14. Hong, S. E., Shugart, Y. Y., Huang, D. T., Shahwan, S. A., Grant, P. E., Hourihane, J. O. B., et al. (2000). Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations. Nature Genetics, 20, 93–96.Google Scholar
  15. Impagnatiello, E., Guidotti, A. R., Pesold, O., Dwivedi, Y., Caruncho, H., Pisu, M. G., et al. (1998). A decrease of Reelin expression as a putative vulnerability factor in schizophrenia. Proceedings of National Academic Science USA, 95, 15718–15723.Google Scholar
  16. Ingram, J. L., Stodgell, C. J., Hyman, S. L., Figlewicz, D. A., Weitkamp, L. R., & Rodier, P. M. (2000). Discovery of allelic variants of HOXA1 and HOXB1: Genetic susceptibility to autism spectrum disorders. Teratology, 62, 393–405.PubMedGoogle Scholar
  17. Jarskog, L. F., & Gilmore, J. H. (2000). Developmental expression of Bcl-2 protein in human cortex. Brain Research Developmental Brain Research, 119(2), 225–230.PubMedGoogle Scholar
  18. Jarskog, L. F., Gilmore, J. H., Selinger, E. S., & Lieberman, J. A. (2000). Cortical Bcl-2 protein expression and apoptotic regulation in schizophrenia. Biological Psychiatry, 48, 641–650.PubMedGoogle Scholar
  19. Keller, E., Persico, A. M., Zelante, L., Gasparini, P., D'Agruma, N., Maiorano, N., et al. (2000). Reelin gene alleles and haplotypes are associated with autistic disorder. Society of Neuroscience, 26, 77 (31.11).Google Scholar
  20. Lacor, P., Grayson, D. R., Auta, J., Sugaya, I., Costa, E., & Guidotti, A. (2000). Reelin secretion from glutamatergic neurons in culture is independent from neurotransmitter regulation. Proceedings of National Academic Science USA, 97, 3556–3561.Google Scholar
  21. Margolis, R. L., Chuang, D. M., & Post, R. M. (1994). Programmed cell death: Implications for neuropsychiatric disorders. Biological Psychiatry, 35, 946–956.PubMedGoogle Scholar
  22. Marshall, K. A., Daniel, S. E., Cairns, N., Jenner, P., & Halliwell, B. (1997). Upregulation of the anti-apoptotic protein Bcl-2 may be an early event in neurodegenerate studies on Parkinson's and incidental Lewy body disease. Biochemical and Biophysical Research Communications, 240, 84–87.PubMedGoogle Scholar
  23. Ogawa, M., Miyata, T., Nakajima, K., Yagyu, K., Selke, M., Ikenake, K., et al. (1995). The reeler gene-associated antigen on Cajal-Retzius neurons is a crucial molecule for laminar organization of cortical neurons. Neuron, 14, 800–912.Google Scholar
  24. Persico, A. M., Agruma, L. D., Maiorano, N., Totaro, A., Militerni, R., Bravaccio, C., et al. (2001) Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder. Molecular Psychiatry, 6, 150–159.PubMedGoogle Scholar
  25. Ritvo, E. R., Freeman, B. J., Schweibel, A. B., Duong, T., Robinson, H., Guthrie, D., & Ritvo, A. (1986). Lower Purkinje cell counts in the cerebella of four autistic subjects: Initial findings of the UCLA-NSAC autopsy research report. American Journal Psychiatry, 143, 862–866.Google Scholar
  26. Smallheiser, N. R., Costa, E., Guidotti, A., Impagnatiello, F., Auta, J., Lacor, P., et al. (2000). Expression of Reelin in adult mammalian blood, liver, pituitary pars intermedia, and adrenal chromoffin cells. Proceedings of National Academic Science USA, 97, 1281–1285.Google Scholar
  27. Tueting, P., Costa, E., Dwivedi, Y., Guidotti, A., et al. (1999). The phenotypic characteristics of heterozygous reeler mouse. NeuroReport, 10, 1327–1334.Google Scholar
  28. Vyas, S., Javoy-Agid, F., Herrero, M. T., Strada, O., Boissiere, F., Hibner, U., & Agid, Y. (1997). Expression of Bcl-2 in adult human brain regions with special reference to neurodegenerate disorders. Journal of Neurochemistry, 69, 223–231.PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 2001

Authors and Affiliations

  • S. Hossein Fatemi
    • 1
    • 2
    • 3
  • Joel M. Stary
    • 1
  • Amy R. Halt
    • 1
  • George R. Realmuto
    • 2
    • 4
  1. 1.Department of PsychiatryUniversity of Minnesota Medical SchoolMinneapolis
  2. 2.Department of NeuroscienceUniversity of Minnesota Medical SchoolMinneapolis
  3. 3.Division of Neuroscience ResearchUSA
  4. 4.Division of Child PsychiatryUSA

Personalised recommendations